WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Trial Evaluating the Efficacy of a Chlorhexidine-Impregnated Sponge (BIOPATCH®) to Reduce Catheter-Related Bloodstream Infections in Hemodialysis Patients

Phase 4

Completed

Conditions: Catheter Related Bloodstream Infection

Interventions: Device: Chlorhexidine-impregnated foam dressing

First Posted Date: 2007-10-30

Last Posted Date: 2007-10-30

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 121

Registration Number: NCT00550693

Locations: 🇺🇸
Barnes-Jewish Dialysis Center, Saint Louis, Missouri, United States
🇺🇸
Chromalloy American Kidney Center, Saint Louis, Missouri, United States

Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer

Phase 2

Completed

Conditions: Cervical Cancer

Interventions: Drug: Topotecan
Drug: Cisplatin
Drug: Bevacizumab

First Posted Date: 2007-10-24

Last Posted Date: 2014-08-01

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 27

Registration Number: NCT00548418

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States
🇺🇸
Duke Cancer Institute, Durham, North Carolina, United States
🇺🇸
The Ohio State University College of Medicine, Columbus, Ohio, United States

Reducing Catheter-Related Bloodstream Infections in the ICU With a Chlorhexidine-Impregnated Sponge (BIOPATCH)

Phase 4

Completed

Conditions: Catheter-related Bloodstream Infection

Interventions: Device: Chlorhexidine-impregnated foam dressing

First Posted Date: 2007-10-23

Last Posted Date: 2013-09-12

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 1088

Registration Number: NCT00548132

Locations: 🇺🇸
Barnes- Jewish Hospital, Saint Louis, Missouri, United States

Lenalidomide in Older Patients With Acute Myeloid Leukemia Without Chromosome 5q Abnormalities

Phase 2

Completed

Conditions: Leukemia, Myeloid, Acute

Interventions: Drug: Lenalidomide

First Posted Date: 2007-10-19

Last Posted Date: 2014-09-29

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 48

Registration Number: NCT00546897

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

A Clinical Trial of Proton Pump Inhibitors to Treat Children With Chronic Otitis Media With Effusion

Not Applicable

Completed

Conditions: Otitis Media With Effusion

Interventions: Drug: lansoprazole
Drug: placebo

First Posted Date: 2007-10-18

Last Posted Date: 2018-06-01

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 16

Registration Number: NCT00546117

Locations: 🇺🇸
St. Louis Children's Hospital, Saint Louis, Missouri, United States

A Phase I Study Of Thymoglobulin In Patients With Relapsed Or Refractory Multiple Myeloma

Phase 1

Completed

Conditions: Relapsed Or Refractory Multiple Myeloma

Interventions: Drug: thymoglobulin

First Posted Date: 2007-10-17

Last Posted Date: 2013-04-23

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 6

Registration Number: NCT00545519

Locations: 🇺🇸
Washington Unvierstiy in St. Louis, St. Louis, Missouri, United States

Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma

Phase 2

Completed

Conditions: Hodgkin Disease

Interventions: Drug: Lenalidomide

First Posted Date: 2007-10-05

Last Posted Date: 2017-11-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 80

Registration Number: NCT00540007

Locations: 🇺🇸
Ohio State University, Columbus, Ohio, United States
🇺🇸
Washington University, Saint Louis, Missouri, United States
🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

and more 2 locations

Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement

Phase 2

Terminated

Conditions: Colorectal Cancer
Metastases

Interventions: Drug: Cetuximab
Drug: Bevacizumab
Drug: Leucovorin
Drug: Oxaliplatin
Drug: Fluorouracil

First Posted Date: 2007-10-01

Last Posted Date: 2016-12-20

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 9

Registration Number: NCT00537823

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Accuracy of FDG-PET Scanning to Diagnose Malignant Thyroid Nodules

Not Applicable

Completed

Conditions: Thyroid Neoplasms

Interventions: Other: FDG-PET Scan

First Posted Date: 2007-10-01

Last Posted Date: 2014-09-22

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 84

Registration Number: NCT00537797

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States
🇺🇸
St. Louis University School of Medicine, St. Louis, Missouri, United States
🇺🇸
VAMC, St. Louis, Missouri, United States

Epoetin Alfa for HIV-Associated Neuropathy Trial

Phase 2

Withdrawn

Conditions: HIV Infections
Neuropathy

Interventions: Drug: epoetin alfa

First Posted Date: 2007-09-12

Last Posted Date: 2011-08-09

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT00528593

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy